Next-generation oncology devices are advanced medical devices that are designed to diagnose, treat, and manage cancer. These devices are typically based on cutting-edge technologies, such as nanotechnology, genomics, and imaging, which enable more precise and personalized approaches to cancer treatment. The global next-generation oncology devices and solutions market is anticipated to increase by USD 1.5 billion till 2029 at an average annual growth of 6 percent as per the latest market estimates.

The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global next-generation oncology devices and solutions market. It presents a quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities. The report also identifies top segments for opportunities and strategies based on market trends and leading competitors’ approaches.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the type, application, end user, and region. The global market for next-generation oncology devices and solutions can be segmented by type: devices, software. The software segment held the largest revenue share in 2022. Next-generation oncology devices and solutions market is further segmented by application: breast cancer, lung cancer, prostate cancer, others. Among these, the breast cancer segment was accounted for the highest revenue generator in 2022. Based on end user, the next-generation oncology devices and solutions market is segmented into: diagnostic imaging centers, hospitals, others. The hospitals segment captured the largest share of the market in 2022. On the basis of region, the next-generation oncology devices and solutions market also can be divided into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. According to the research, North America had the largest share in the global next-generation oncology devices and solutions market.

Market Segmentation
By type: devices, software
By application: breast cancer, lung cancer, prostate cancer, others
By end user: diagnostic imaging centers, hospitals, others
By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America

The market research report covers the analysis of key stake holders of the global next-generation oncology devices and solutions market. Some of the leading players profiled in the report include Accuray Incorporated, E.ON SE, Elekta AB, Koninklijke Philips N.V., Siemens AG, among others. In this report, key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Scope of the Report
• To analyze and forecast the market size of the global next-generation oncology devices and solutions market.
• To classify and forecast the global next-generation oncology devices and solutions market based on type, application, end user, region.
• To identify drivers and challenges for the global next-generation oncology devices and solutions market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global next-generation oncology devices and solutions market.
• To identify and analyze the profile of leading players operating in the global next-generation oncology devices and solutions market.

Why Choose This Report
• Gain a reliable outlook of the global next-generation oncology devices and solutions market forecasts from 2023 to 2029 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.